KOOKMIN BIO
Latest round
- Series B
Last raised
- Nov 2024
Total raised
- $4M
Investors
- 6
About KOOKMIN BIO
KOOKMIN BIO, founded in 2019 in Jeonju, South Korea, focuses on creating microbiome health products.Kookmin Bio specializes in the development of microbiome-based health solutions aimed at enhancing consumer well-being through innovative food and pharmaceutical products. Their core offerings include postbiotics boosters, soy-based convenience foods, and health supplements designed to support muscle recovery and weight management. These products utilize proprietary fermentation technologies that combine beneficial lactic acid bacteria with domestic soybean powder to improve nutrient absorption and promote overall health.Kookmin Bio operates on a business model that encompasses both direct-to-consumer sales and partnerships with retailers to distribute its innovative health products. The company engages in B2B transactions with health retailers and wellness providers, facilitating a range of product offerings tailored to meet the needs of various client demographics. Their flagship products, such as the fermented soy milk and postbiotic boosters, are positioned within the health and wellness market, providing consumers with targeted solutions for muscle enhancement and weight management. The company is also targeting expansion into international markets, although specific regions and timelines have not been detailed. Upcoming product launches are anticipated as part of their strategy to enhance their market presence.
Who invested in KOOKMIN BIO
6 investors across 3 rounds
See all investors in KOOKMIN BIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KOOKMIN BIO
Who invested in KOOKMIN BIO?
KOOKMIN BIO has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KOOKMIN BIO raised?
KOOKMIN BIO has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did KOOKMIN BIO last raise money?
KOOKMIN BIO's most recent round on record is a Series B, in Nov 2024.
What does KOOKMIN BIO do?
KOOKMIN BIO, founded in 2019 in Jeonju, South Korea, focuses on creating microbiome health products.
Where is KOOKMIN BIO headquartered?
KOOKMIN BIO is headquartered in Jeonju, South Korea.
Which VCs invest in companies like KOOKMIN BIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at KOOKMIN BIO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like KOOKMIN BIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.